DIAGNOSTIC AND THERAPEUTIC CENTER OF ATHENS HYGEIA SA General Commercial Registry No.: 279901000 Company Registration No.: 13165/06/B/86/14 NOTICE TO THE ANNUAL GENERAL MEETING OF SHAREHOLDERS

By decision of the Board of Directors (BoD) of the Company trading under

"DIAGNOSTIC AND THERAPEUTIC CENTRE OF ATHENS HYGEIA SA", which

was taken during the meeting on 03/04/2017, the Company Shareholders are invited to attend the Annual General Meeting on Thursday 04/05/2017, at 17:30 hours, to deliberate on the following Agenda Items, in accordance with the legislation in force and the Company's Articles of Incorporation. The Meeting will take place in the Nikolaos Louros Conference Center, located on the first level (ground floor) of MITERA Hospital, at 6 Erythrou Stavrou Street, Marousi, Attica.

ITEMS ON THE AGENDA
  1. Submission and approval of the Separate and Consolidated Financial Statements for the 2016 fiscal year, and the respective reports of the BoD and the Chartered Accountants/Auditors.

  2. Discharge of BoD members and Chartered Accountants/Auditors from any liability with regard to the 2016 fiscal year activities.

  3. Appointment of Chartered Accountants/Auditors for the 2017 fiscal year.

  4. Approval of remunerations and contracts in accordance with Articles 23a and 24 of Codified Law 2190/1920.

  5. Approval of replacements of BoD and Control Committee Members.

  6. Other issues/announcements.

In case that the quorum required by Law for deliberation on any of the Agenda Items is not attained, a 1st Reiterative Annual General Meeting (if required) will be held on Tuesday 16/05/2017, at 17:30 hours, at the same location.

Pursuant to Article 26, paragraph 2b of Codified Law 2190/1920, as amended by Article 3 of Law 3884/2010 and currently in force, the Company hereby informs the shareholders on the following:

RIGHT OF PARTICIPATION

According to the Articles of Incorporation, any person appearing as shareholder in the registry of the Dematerialized Securities System, managed by the HELLENIC CENTRAL SECURITIES DEPOSITORY (ATHEXCSD), where the Company's shares are recorded, is entitled to participate, either in person or by proxy, in the Annual General Meeting and any subsequent Reiterative Meetings. Proof of qualification as a shareholder may be made by presenting a relevant certification of the aforementioned organization or alternatively through direct electronic connection of the Company with the records of said organization.

The qualification as shareholder must exist on 29/04/2017 (Record Date), i.e. at the beginning of the 5th day before the date of the Annual General Meeting, and the

relevant written certification or electronic verification regarding the shareholder's qualification must have been received by the Company on 01/05/2017 at the latest,

i.e. on the 3rd day before date of the General Meeting.

For the 1st Reiterative Annual General Meeting, the qualification as a shareholder must exist on 12/05/2017 (Record Date of 1st Reiterative Annual General Meeting),

i.e. at the beginning of the 4th day before the date of the 1st Reiterative Annual General Meeting, and the relevant written certification or electronic verification

indicating their shareholding qualification must have been received by the Company on 13/05/2017 at the latest, i.e. on the 3rd day before said General Meeting.

Only those who are qualified as shareholders on the respective Record Date are considered by the Company as entitled to participate and vote in the General Meeting. Shareholders who do not comply with the provisions of Article 28a of Codified Law 2190/1920 may participate in the General Meeting only if the Meeting has authorized them to do so.

The exercise of the aforementioned rights does not presuppose blocking of shares or following any other similar process which may limit the possibility to sell or transfer the shares during a certain period between the Record Date and the General Meeting.

PROCEDURE FOR VOTING BY PROXY

Shareholders may participate in the General Meeting and may vote either in person or by proxy holders.

Appointment and revocation of a proxy holder shall be made in writing at least 3 days before the General Meeting. In particular, for the Annual General Meeting scheduled on 04/05/2017, the appointment and revocation of a proxy holder must be performed in writing by 01/05/2017, while for the 1st Reiterative General Meeting scheduled on 16/05/2017, by 13/05/2017. Shareholders wishing to participate in the Annual or the 1st Reiterative General Meeting (if required) by proxy holder, or revoke the appointment of said proxy holder, must fill out, duly sign and submit the relevant representation form to the Company's Investor Relations Department (6 Erythrou Stavrou St. & Kifisias Ave., Marousi 15123, Attica), within the aforementioned deadlines. The form is available through the Company's website (www.hygeia.gr), under the heading Investor Relations.

Each shareholder may appoint up to 3 proxy holders. Legal persons may participate in the General Meeting by appointing up to 3 natural persons as proxy holders. If a shareholder has Company shares held in more than one investor share account, this limitation shall not prevent the shareholder from appointing separate proxy holders for the shares held in each account in relation to the General Meeting. A proxy holder holding proxies from several shareholders may cast votes for a certain shareholder differently from votes cast for another shareholder.

Before the commencement of the General Meeting, the proxy holder is obliged to disclose to the Company every specific fact that may be relevant for the shareholders in assessing any risk of the proxy holder pursuing any interest other than the interest of the shareholder. A conflict of interest may arise in particular where the proxy holder: (i) is a controlling shareholder of the Company or is another legal person or entity controlled by such shareholder, (ii) is a member of the Company's BoD or the Company's Management in general, or of a controlling shareholder, or another legal person or entity controlled by such shareholder, (iii) is an employee or an auditor of the Company or of a controlling shareholder, or of a legal person or entity controlled by such shareholder, (iv) is a spouse or first degree relative of a natural person referred to in points (i) to (iii).

The Company's Articles do not provide the possibility for the shareholders to participate in the General Meetings by electronic media without attending the Meeting

in person at the place where it is held, or the possibility to participate in the voting by distance.

MINORITY RIGHTS

  1. Following a request from shareholders representing 1/20 of the paid-up share capital, the Company's BoD is obliged to include in the Agenda of the General Meeting additional items, if that request is communicated to the BoD by 19/04/2017,

    i.e. at least 15 days before the General Meeting. The request for putting additional items on the agenda shall be accompanied by a justification or a draft resolution to be adopted in the General Meeting and the revised agenda shall be published in the same manner as the previous agenda on 21/04/2017, i.e. 13 days before the date of the General Meeting, and at the same time, shall also be made available to the shareholders through the Company's website, along with the justification or draft resolution submitted by the shareholders, as provided by Article 27, Paragraph 3 of Codified Law 2190/1920.

  2. Following a request from shareholders representing 1/20 of the paid-up share capital, and in accordance with Article 27, Paragraph 3 of Codified Law 2190/1920, the BoD is obliged to make available to shareholders a draft resolution for the items included in the initial or revised agenda by 28/04/2017 at the latest, i.e. at least 6 days before the date of the General Meeting, if the relevant request is communicated to the BoD by 27/04/2017, i.e. at least 7 days before the date of the General Meeting.

  3. Following a request from any shareholder communicated to the Company by 28/04/2017, i.e. at least 6 full days before the General Meeting, the BoD must provide to the General Meeting the requested specific information with regard to the Company affairs, in so far as the information is useful for the actual assessment of the items on the agenda. The BoD may decline to provide the information on a serious, substantive ground, which must be mentioned in the minutes. The BoD may provide an overall response to shareholder requests having the same content. The obligation to provide information does not exist if the relevant information is already available on the Company's website. Following a request from shareholders representing 1/20 of the paid-up share capital, the BoD must announce to the Annual General Meeting any amounts paid over the last two years to each member of the BoD or Managers of the Company and all remuneration given to those persons on any ground or under any contract between them and the Company. The BoD may decline to provide the information on a serious, substantive ground, which must be mentioned in the minutes.

  4. Following a request of shareholders representing 1/5 of the paid-up share capital, which is communicated to the Company by 28/04/2017, i.e. at least 6 full days before the General Meeting, the BoD must provide the General Meeting with information on the course of Company's affairs and financial status. The BoD may decline to provide the information on a serious, substantive ground, which must be mentioned in the minutes.

Corresponding terms for exercise of minority rights also apply in the case of Reiterative General Meetings.

In all the aforementioned cases, the requesting shareholders must prove their qualification as shareholders and state the number of shares held by them at the moment they exercise the relevant right. Presentation of a certification from the organization which records the relevant Company shares or verification of the qualification as shareholder through direct electronic connection between said organization and the Company may also be considered as such proof.

AVAILABLE DOCUMENTS AND INFORMATION

The information of Article 27(3) of Codified Law 2190/2190 will be available in electronic format through the Company's website (www.hygeia.gr), under the heading Investor Relations.

The full text containing the information and items of Article 27(3c & 3d) of Codified Law 2190/1920 will be available in hard copy from the Company's Investor Relations Department, 6 Erythrou Stavrou St. and Kifisias Ave., Marousi, 151 23, Attica (Tel:

+30 210 6869653, Fax: +30 210 6869133).

Masousi, 03/04/2017 For the Board of Directors

The Chairman

Athanasios Papanikolaou

Hygeia SA Diagnostic & Therapeutic Center of Athens published this content on 11 April 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 13 April 2017 07:53:14 UTC.

Original documenthttp://www.hygeia.gr/en/media/files/1404-ΠΡΟΣΚΛΗΣΗ ΤΓΣ 2017 _ENG.pdf

Public permalinkhttp://www.publicnow.com/view/6AD740DB481AE88C3F91C73962E01E33852CAF6F